Yoshikawa Yoshie

ヨシカワヨシエ | Yoshikawa Yoshie

Affiliation and department：
Job title：講師
Research theme for competitive and other funds (10)：

2021 - 2024 低侵襲でハイスループットな悪性中皮腫の早期診断法の確立
2018 - 2021 Identification of molecular mechanism underlying malignant mesothelioma development using conditional mouse model and search of therapeutic target molecules
2018 - 2021 Integrative genomic analysis of malignant mesothelioma to find therapeutic molecular targets
2016 - 2019 Detailed analysis of genome structural alteration on 3p21 and clinical application in environment-related cancers.
2015 - 2018 Analysis on genomic instability in malignant mesotheliomas of Japanese patients as therapeutic targets

Show all

Papers (25)：

Misato Takagi-Kimura, Akio Tada, Takashi Kijima, Shuji Kubo, Masaki Ohmuraya, Yoshie Yoshikawa. BAP1 depletion in human B-lymphoblast cells affects the production of innate immune cytokines and chemokines. Genes to cells : devoted to molecular & cellular mechanisms. 2022
Yoshie Yoshikawa, Yusuke Yamada, Mitsuru Emi, Lilit Atanesyan, Jan Smout, Karel de Groot, Suvi Savola, Yukako Nakanishi-Shinkai, Akihiro Kanematsu, Michio Nojima, et al. Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification. Cancer science. 2022. 113. 1. 297-307
Kouko Hidaka, Tetsushi Takeda, Yoshiaki Kinoshita, Kazuki Nabeshima, Sadafumi Tamiya, Yoshie Yoshikawa, Tohru Tsujimura. Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years. Pathology international. 2020. 70. 12. 1009-1014
Yoshie Yoshikawa, Mitsuru Emi, Takashi Nakano, Giovanni Gaudino. Mesothelioma developing in carriers of inherited genetic mutations. Translational lung cancer research. 2020. 9. Suppl 1. S67-S76
Sandra Pastorino, Yoshie Yoshikawa, Harvey I Pass, Mitsuru Emi, Masaki Nasu, Ian Pagano, Yasutaka Takinishi, Ryuji Yamamoto, Michael Minaai, Tomoko Hashimoto-Tamaoki, et al. A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018. JCO2018790352

ｍore...

MISC (1)：

Yoshie Yoshikawa, Kozo Kuribayashi, Toshiyuki Minami, Masaki Ohmuraya, Takashi Kijima. Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment. Frontiers in Oncology. 2020. 10

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page